Article
15 Aug 2023
Patent claims to metabolites in Australia: when will use of a prodrug be infringing?
AUTHORS CONTENT
Article
18 Jan 2023
Novel foods, novel field: patent validity issues in the new foods landscape
Article
02 Nov 2022
Therapeutic antibody patent claims
Article
31 Aug 2022
Partial jackpot: split High Court relaxes, but does not resolve, the patentability test for computer-enabled inventions
Article
23 Aug 2022
Intellectual property and brand jamming: an international snapshot
Article
22 Jun 2022
Cell culture foods: considering the legal issues
Article
01 Apr 2022
Patent settlement agreements: ACCC options and challenges
Article
31 Mar 2022
Extensions of term for patents covering multiple approved pharmaceutical substances clarified
Article
26 May 2021
Compulsory patent licences in Australia: time to take another look?
Article
05 May 2020
Shifting the starting line: regulatory changes to impact Australian pharma patent disputes
Article
23 Jan 2020
Pharmaceutical and life sciences advertising to healthcare professionals - guidance from the courts
Article
08 Jan 2020
Full Federal Court decision represents useful guidance on additional damages for patent infringement
Article
02 Jul 2019
Trade mark use control requirements in a corporate group eased by recent Full Federal Court decision
Article
30 Jan 2019
Motorola v Hytera update: discovery, state security laws and copyright infringement in issue in digital mobile radio patent dispute
Article
23 Jan 2018
Motorola v Hytera: Standard essential patents to be considered by Federal Court
Article
05 Jul 2017
Commercialising cannabis in Australia: A budding industry
Article
07 Sep 2016
Registered designs: What is the appropriate form of order for injunctive relief?
Article
02 Sep 2016
Experimental evidence in patent cases: Discovery not available for experiments on matters no longer in issue
Article
13 Aug 2015
The power of architect plan copyright
Article
15 Sep 2014
Trade mark use and the internet – keywords and search engine optimisation
